BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30780843)

  • 1. Carglumic acid for the treatment of N-acetylglutamate synthase deficiency and acute hyperammonemia.
    Häberle J
    Expert Rev Endocrinol Metab; 2012 May; 7(3):263-271. PubMed ID: 30780843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency.
    Häberle J
    Ther Clin Risk Manag; 2011; 7():327-32. PubMed ID: 21941437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carglumic acid enhances rapid ammonia detoxification in classical organic acidurias with a favourable risk-benefit profile: a retrospective observational study.
    Valayannopoulos V; Baruteau J; Delgado MB; Cano A; Couce ML; Del Toro M; Donati MA; Garcia-Cazorla A; Gil-Ortega D; Gomez-de Quero P; Guffon N; Hofstede FC; Kalkan-Ucar S; Coker M; Lama-More R; Martinez-Pardo Casanova M; Molina A; Pichard S; Papadia F; Rosello P; Plisson C; Le Mouhaer J; Chakrapani A
    Orphanet J Rare Dis; 2016 Mar; 11():32. PubMed ID: 27030250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylglutamate synthase deficiency: an insight into the genetics, epidemiology, pathophysiology, and treatment.
    Ah Mew N; Caldovic L
    Appl Clin Genet; 2011; 4():127-35. PubMed ID: 23776373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Experience of Carglumic Acid for Methylmalonic and Propionic Acidurias: An Interim Analysis of the Multicentre Observational PROTECT Study.
    Yap S; Lamireau D; Feillet F; Ruiz Gomez A; Davison J; Tangeraas T; Giordano V
    Drugs R D; 2024 Mar; 24(1):69-80. PubMed ID: 38198106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of Carbamylglutamate impacts the nutritional management of patients with N-Acetylglutamate synthase deficiency.
    Singh RH; Bourdages MH; Kurtz A; MacLoed E; Norman C; Ratko S; van Calcar SC; Kenneson A
    Orphanet J Rare Dis; 2024 Apr; 19(1):168. PubMed ID: 38637895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial N-acetyl glutamate synthase deficiency presenting as postpartum hyperammonemia: Diagnosis and subsequent pregnancy management.
    Abou Haidar L; Pachnis P; Gotway GK; Ni M; DeBerardinis RJ; McNutt MC
    JIMD Rep; 2023 Nov; 64(6):403-409. PubMed ID: 37927481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation and management of N-acetylglutamate synthase deficiency: a review of the literature.
    Kenneson A; Singh RH
    Orphanet J Rare Dis; 2020 Oct; 15(1):279. PubMed ID: 33036647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of long-term effectiveness of the use of carglumic acid in patients with propionic acidemia (PA) or methylmalonic acidemia (MMA): study protocol for a randomized controlled trial.
    Nashabat M; Obaid A; Al Mutairi F; Saleh M; Elamin M; Ahmed H; Ababneh F; Eyaid W; Alswaid A; Alohali L; Faqeih E; Aljeraisy M; Hussein MA; Alasmari A; Alfadhel M
    BMC Pediatr; 2019 Jun; 19(1):195. PubMed ID: 31196016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylglutamate synthase deficiency: Novel mutation associated with neonatal presentation and literature review of molecular and phenotypic spectra.
    Al Kaabi EH; El-Hattab AW
    Mol Genet Metab Rep; 2016 Sep; 8():94-8. PubMed ID: 27570737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncoding sequence variants define a novel regulatory element in the first intron of the N-acetylglutamate synthase gene.
    Häberle J; Moore MB; Haskins N; Rüfenacht V; Rokicki D; Rubio-Gozalbo E; Tuchman M; Longo N; Yandell M; Andrews A; AhMew N; Caldovic L
    Hum Mutat; 2021 Dec; 42(12):1624-1636. PubMed ID: 34510628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene delivery corrects N-acetylglutamate synthase deficiency and enables insights in the physiological impact of L-arginine activation of N-acetylglutamate synthase.
    Sonaimuthu P; Senkevitch E; Haskins N; Uapinyoying P; McNutt M; Morizono H; Tuchman M; Caldovic L
    Sci Rep; 2021 Feb; 11(1):3580. PubMed ID: 33574402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel UPLC-MS/MS based method to determine the activity of N-acetylglutamate synthase in liver tissue.
    Dercksen M; Duran M; IJlst L; Kulik W; Ruiter JP; van Cruchten A; Tuchman M; Wanders RJ
    Mol Genet Metab; 2016 Dec; 119(4):307-310. PubMed ID: 27771289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid.
    Lazier J; Lupichuk SM; Sosova I; Khan AA
    Curr Oncol; 2014 Oct; 21(5):e736-9. PubMed ID: 25302046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-carbamylglutamate treatment for acute neonatal hyperammonemia in isovaleric acidemia.
    Kasapkara CS; Ezgu FS; Okur I; Tumer L; Biberoglu G; Hasanoglu A
    Eur J Pediatr; 2011 Jun; 170(6):799-801. PubMed ID: 21207059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in the treatment of hyperammonemia: emerging use of carglumic acid.
    Daniotti M; la Marca G; Fiorini P; Filippi L
    Int J Gen Med; 2011 Jan; 4():21-8. PubMed ID: 21403788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Acetylglutamate Synthase Deficiency Due to a Recurrent Sequence Variant in the N-acetylglutamate Synthase Enhancer Region.
    Williams M; Burlina A; Rubert L; Polo G; Ruijter GJG; van den Born M; Rüfenacht V; Haskins N; van Zutven LJCM; Tuchman M; Saris JJ; Häberle J; Caldovic L
    Sci Rep; 2018 Oct; 8(1):15436. PubMed ID: 30337552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA.
    Aires CC; van Cruchten A; Ijlst L; de Almeida IT; Duran M; Wanders RJ; Silva MF
    J Hepatol; 2011 Aug; 55(2):426-34. PubMed ID: 21147182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylglutamate synthase: structure, function and defects.
    Caldovic L; Ah Mew N; Shi D; Morizono H; Yudkoff M; Tuchman M
    Mol Genet Metab; 2010; 100 Suppl 1(Suppl 1):S13-9. PubMed ID: 20303810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inversion of allosteric effect of arginine on N-acetylglutamate synthase, a molecular marker for evolution of tetrapods.
    Haskins N; Panglao M; Qu Q; Majumdar H; Cabrera-Luque J; Morizono H; Tuchman M; Caldovic L
    BMC Biochem; 2008 Sep; 9():24. PubMed ID: 18801197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.